[Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
Feu
F
F
Laboratorio de Hemodinámica Hepática, Unidad de Hepatología, Hospital Clínic i Provincial de Barcelona.
Bosch
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000818:Animals; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D004285:Dogs; D004932:Esophageal and Gastric Varices / Q000150:complications; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy / Q000209:etiology; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006727:Hormone Antagonists / Q000627:therapeutic use*; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications; D007412:Intestinal Fistula / Q000188:drug therapy; D007415:Intestinal Obstruction / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*; D010179:Pancreas / Q000601:surgery; D010185:Pancreatic Fistula / Q000188:drug therapy; D010195:Pancreatitis / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D012778:Short Bowel Syndrome / Q000188:drug therapy; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D013997:Time Factors
D005765:Gastrointestinal Agents; D006727:Hormone Antagonists; D013004:Somatostatin; D015282:Octreotide